Ellipses Pharma
Clinical trials sponsored by Ellipses Pharma, explained in plain language.
-
New hope for hard-to-treat blood cancers? early trial begins.
Disease control Recruiting nowThis study tests a new experimental drug called EP0042, alone or with other cancer treatments, in adults with advanced acute myeloid leukemia (AML) or related blood cancers. The main goal is to find a safe dose that might work against the cancer. About 70 people will take part in…
Phase: PHASE1, PHASE2 • Sponsor: Ellipses Pharma • Aim: Disease control
Last updated May 17, 2026 02:54 UTC
-
New hope for advanced breast cancer: experimental drug EP0062 enters human trials
Disease control Recruiting nowThis study tests an experimental drug called EP0062, alone or with standard treatments, in people with a certain type of advanced breast cancer (AR+/HER2-/ER+) that has come back or spread. The main goals are to find the safest dose and see if it helps shrink tumors. About 95 adu…
Phase: PHASE1, PHASE2 • Sponsor: Ellipses Pharma • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New targeted drug EP0031 enters human trials for hard-to-treat RET-altered cancers
Disease control Recruiting nowThis study tests a new drug called EP0031 in about 265 adults with advanced cancers (like non-small cell lung cancer) that have a specific RET gene change. The goal is to see if the drug is safe, what side effects it causes, and how well it shrinks tumors. Participants must have …
Phase: PHASE1, PHASE2 • Sponsor: Ellipses Pharma • Aim: Disease control
Last updated May 11, 2026 20:48 UTC